The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
Abstract
Orexins/hypocretins are key neuropeptides responsible for regulating central arousal and reward circuits. Two receptors respond to orexin signaling, orexin 1 receptor (OX(1)R) and orexin 2 receptor (OX(2)R) with partially overlapping nervous system distributions. Genetic studies suggest orexin receptor antagonists could be therapeutic for insomnia and other disorders with disruptions of sleep and wake. Suvorexant (MK-4305) is a potent, selective, and orally bioavailable antagonist of OX(1)R and OX(2)R currently under clinical investigation as a novel therapy for insomnia. Examination of Suvorexant in radioligand binding assays using tissue from transgenic rats expressing the human OX(2)R found nearly full receptor occupancy (>90%) at plasma exposures of 1.1 μM. Dosed orally Suvorexant significantly and dose-dependently reduced locomotor activity and promoted sleep in rats (10, 30, and 100 mg/kg), dogs (1 and 3 mg/kg), and rhesus monkeys (10 mg/kg). Consistent cross-species sleep/wake architecture changes produced by Suvorexant highlight a unique opportunity to develop dual orexin antagonists as a novel therapy for insomnia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mixed-Effects Models in S and S-PLUS
(2001) · Technometrics · doi:10.1198/tech.2001.s574 · Cited by 9,278 · cited 1×
“Mixed models were fi t in the R statistical computing environment (cran.us.r-project.org; the R Foundation for Statistical Computing, Vienna, Austria) with the nlme package (Pinheiro & Bates, 2002).”
MethodSakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501 · cited 2×
“…are primarily silent during sleep (Estabrooke et al., 2001; Lee et al., 2005) and active during wakefulness, with exogenous administration of orexin peptides promoting wake in rodents, dogs, and monkeys (Deadwyler et al., 2007; Fujiki et al., 2003; Sakurai et al., 1998; Winrow et al., 2010).”
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878 · cited 1×
“Orexins (also known as hypocretins) are peptide neurotransmitters discovered independently using forward (Sakurai et al., 1998) and reverse genetic techniques (de Lecea et al., 1998; Gautvik et al., 1996).”
BackgroundNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 5×
“The hypersomnolence phenotype of mice and rats lacking either orexin-secreting neurons or the prepro-orexin gene is more pervasive than that of OX 2 R mutant mice (Beuckmann et al., 2004; Chemelli et al., 1999; Hara et al., 2001; Willie et al., 2003).”
BackgroundInfluentialLin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Differential expression of orexin receptors 1 and 2 in the rat brain
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., & Elmquist, J. K. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1190 · Cited by 1,659
Sleep Complaints Among Elderly Persons: An Epidemiologic Study of Three Communities
Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B., & Blazer, D. G. (1995) · Sleep · doi:10.1093/sleep/18.6.425 · Cited by 1,610
Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity
Hara, J., Beuckmann, C. T., Nambu, T., Willie, J. T., Chemelli, R. M., Sinton, C. M., Sugiyama, F., Yagami, K.-I., Goto, K., Yanagisawa, M., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00293-8 · Cited by 1,403
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10911 · Cited by 1,234 · cited 1×
“…to rodents is suffi cient to induce locomotor activity and active wake increases at the expense of non-REM and REM sleep (Akanmu & Honda, 2005; Hagan et al., 1999; Piper et al., 2000; Winrow et al., 2010), whereas genetic disruption of orexin pathways is associated with hypersomnolence in…”
BackgroundDischarge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle
Lee, M. G., Hassani, O. K., & Jones, B. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1887-05.2005 · Cited by 871
Behavioral Correlates of Activity in Identified Hypocretin/Orexin Neurons
Mileykovskiy, B. Y., Kiyashchenko, L. I., & Siegel, J. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.035 · Cited by 848
To Eat or to Sleep? Orexin in the Regulation of Feeding and Wakefulness
Willie, J. T., Chemelli, R. M., Sinton, C. M., & Yanagisawa, M. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.429 · Cited by 766
Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., & Bonci, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.016 · Cited by 718 · cited 2×
“…nicotine reinstatement, cocaine sensitization, morphine relapse, alcohol seeking, and amphetamine self-administration (Aston-Jones et al., 2009; Borgland et al., 2006; Moorman & Aston-Jones, 2009; Winrow et al., 2010) effects potentially related to the ability of OX 1 R to modulate dopamine…”
BackgroundFos Expression in Orexin Neurons Varies with Behavioral State
Estabrooke, I. V., McCarthy, M. T., Ko, E., Chou, T. C., Chemelli, R. M., Yanagisawa, M., Saper, C. B., & Scammell, T. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01656.2001 · Cited by 654
Distinct Narcolepsy Syndromes in Orexin Receptor-2 and Orexin Null Mice
Willie, J. T., Chemelli, R. M., Sinton, C. M., Tokita, S., Williams, S. C., Kisanuki, Y. Y., Marcus, J. N., Lee, C., Elmquist, J. K., Kohlmeier, K. A., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00330-1 · Cited by 645
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., Mueller, C., Nayler, O., van Gerven, J., de Haas, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1544 · Cited by 573
Arousal effect of orexin A depends on activation of the histaminergic system
Huang, Z.-L., Qu, W.-M., Li, W.-D., Mochizuki, T., Eguchi, N., Watanabe, T., Urade, Y., & Hayaishi, O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181330998 · Cited by 553
Yoshida, Y., Fujiki, N., Nakajima, T., Ripley, B., Matsumura, H., Yoneda, H., Mignot, E., & Nishino, S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01725.x · Cited by 448
Mixed-Effects Models in S and S-Plus
Carey, V. J., & Wang, Y.-G. (2001) · Journal of the American Statistical Association · doi:10.1198/jasa.2001.s411 · Cited by 403
Behavioral State Instability in Orexin Knock-Out Mice
Mochizuki, T., Crocker, A., McCormack, S., Yanagisawa, M., Sakurai, T., & Scammell, T. E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0586-04.2004 · Cited by 397
Cox, C. D., Breslin, M. J., Whitman, D. B., Schreier, J. D., McGaughey, G. B., Bogusky, M. J., Roecker, A. J., Mercer, S. P., Bednar, R. A., Lemaire, W., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100541c · Cited by 379
Self-citationThe novel brain neuropeptide, orexin‐A, modulates the sleep–wake cycle of rats
Piper, D. C., Upton, N., Smith, M. I., & Hunter, A. J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00919.x · Cited by 351
Role of lateral hypothalamic orexin neurons in reward processing and addiction
Aston-Jones, G., Smith, R. J., Moorman, D. E., & Richardson, K. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.060 · Cited by 322
Insomnia in the Elderly: Cause, Approach, and Treatment
Kamel, N. S., & Gammack, J. K. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.051 · Cited by 307
Orexins Activate Histaminergic Neurons via the Orexin 2 Receptor
Yamanaka, A., Tsujino, N., Funahashi, H., Honda, K., Guan, J.-L., Wang, Q.-P., Tominaga, M., Goto, K., Shioda, S., & Sakurai, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6318 · Cited by 298
Zeitzer, J. M., Buckmaster, C. L., Parker, K. J., Hauck, C. M., Lyons, D. M., & Mignot, E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03555.2003 · Cited by 277
Deadwyler, S. A., Porrino, L., Siegel, J. M., & Hampson, R. E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3878-07.2007 · Cited by 265
Gautvik, K. M., de Lecea, L., Gautvik, V. T., Danielson, P. E., Tranque, P., Dopazo, A., Bloom, F. E., & Sutcliffe, J. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8733 · Cited by 263
Diagnosis and Treatment of Chronic Insomnia: A Review
Benca, R. M. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.3.332 · Cited by 251
Dugovic, C., Shelton, J. E., Aluisio, L. E., Fraser, I. C., Jiang, X., Sutton, S. W., Bonaventure, P., Yun, S., Li, X., Lord, B., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152009 · Cited by 230
Fujiki, N., Yoshida, Y., Ripley, B., Honda, K., Mignot, E., & Nishino, S. (2001) · Neuroreport · doi:10.1097/00001756-200104170-00026 · Cited by 216
The orexin system: roles in sleep/wake regulation
Sakurai, T., Mieda, M., & Tsujino, N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05513.x · Cited by 200
Beuckmann, C. T., Sinton, C. M., Williams, S. C., Richardson, J. A., Hammer, R. E., Sakurai, T., & Yanagisawa, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5560-03.2004 · Cited by 183
Fujiki, N., Yoshida, Y., Ripley, B., Mignot, E., & Nishino, S. (2003) · Sleep · doi:10.1093/sleep/26.8.953 · Cited by 179
Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation
Beuckmann, C. T., & Yanagisawa, M. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0322-x · Cited by 159
Moorman, D. E., & Aston‐Jones, G. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.07.002 · Cited by 152
Abnormal Sleep/Wake Dynamics in Orexin Knockout Mice
Behn, C. D., Klerman, E. B., Mochizuki, T., Lin, S., & Scammell, T. E. (2010) · SLEEP · doi:10.1093/sleep/33.3.297 · Cited by 142
Sleep Patterns and Mortality among Elderly Patients in a Geriatric Hospital
Manabe, K., Matsui, T., Yamaya, M., Sato-Nakagawa, T., Okamura, N., Arai, H., & Sasaki, H. (2000) · Gerontology · doi:10.1159/000022184 · Cited by 138
Hypocretins in the Control of Sleep and Wakefulness
Bonnavion, P., & de Lecea, L. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0101-y · Cited by 91
Kunapuli, P., Ransom, R. W., Murphy, K. L., Pettibone, D. J., Kerby, J., Grimwood, S., Zuck, P. D., Hodder, P., Lacson, R., Hoffman, I., et al. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00587-0 · Cited by 85
Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats
Akanmu, M. A., & Honda, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.064 · Cited by 84
Winrow, C. J., Tanis, K. Q., Reiss, D. R., Rigby, A. M., Uslaner, J. M., Uebele, V. N., Doran, S. M., Fox, S. V., Garson, S. L., Gotter, A. L., et al. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.008 · Cited by 83
Self-citationWhitman, D. B., Cox, C. D., Breslin, M. J., Brashear, K. M., Schreier, J. D., Bogusky, M. J., Bednar, R. A., Lemaire, W., Bruno, J. G., Hartman, G. D., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900069 · Cited by 74
Self-citationNew developments for treating sleep disorders.
Roth, T. G. (2001) · PubMed · Cited by 65
Diurnal Variation in CSF Orexin-A in Healthy Male Subjects
Grady, S., Nishino, S., Czeisler, C. A., Hepner, D. L., & Scammell, T. E. (2006) · SLEEP · doi:10.1093/sleep/29.3.295 · Cited by 65
Sub-chronic administration of zolpidem affects modifications to rat sleep architecture
Renger, J. J., Dunn, S. L., Motzel, S. L., Johnson, C. A., & Koblan, K. S. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.067 · Cited by 37
Self-citation
Cited by
Michelson, D., Snyder, E., Paradis, E., Chengan-Liu, M., Snavely, D. B., Hutzelmann, J., Walsh, J. K., Krystal, A. D., Benca, R. M., Cohn, M., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70053-5 · Cited by 519
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
Herring, W. J., Snyder, E., Budd, K., Hutzelmann, J., Snavely, D., Liu, K., Lines, C., Roth, T., & Michelson, D. (2012) · Neurology · doi:10.1212/wnl.0b013e31827688ee · Cited by 322
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
Herring, W. J., Connor, K. M., Ivgy-May, N., Snyder, E., Liu, K., Snavely, D. B., Krystal, A. D., Walsh, J. K., Benca, R. M., Rosenberg, R., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.003 · Cited by 300
The Neurobiology of Sleep and Wakefulness
Schwartz, M. D., & Kilduff, T. S. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.07.002 · Cited by 207
Metadata
- Authors
- Winrow, C. J., Gotter, A. L., Cox, C. D., Doran, S. M., Tannenbaum, P. L., Breslin, M. J., Garson, S. L., Fox, S. V., Harrell, C. M., Stevens, J., Reiss, D. R., Cui, D., Coleman, P. J., & Renger, J. J.
- Venue
- Journal of Neurogenetics
- Publisher
- Informa UK Limited
- Published
- 2011-03
- Volume
- 25
- Issue
- 1-2
- Pages
- 52-61
- ISSN
- 0167-7063 (ISSN-L)
- 1563-5260
- OpenAlex
- W2028353633
- Cited by
- 269
- References
- 47
- FWCI
- 12.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.